DUBLIN, Ohio , June 10, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that LYMPHOSEEK ® (technetium Tc 99m tilmanocept) injection – the first and only radiopharmaceutical ...

Cardinal Health Nuclear & Precision Health Solutions offers an extensive network of over 130 pharmacies, of which more than 110 are licensed to process 68 Ga.

Mike Pintek, President of Cardinal Health Nuclear & Precision Health Solutions, added, “We are pleased to continue to build on our relationship with Telix, which now includes the distribution of ...

The company shared that other segment profit increased 11% to $118 million in the second quarter, driven by the performance of optiFreight logistics and nuclear and precision health solutions ...

Mike Pintek, President of Cardinal Health Nuclear & Precision Health Solutions, added, "This new agreement builds upon our successful relationship with Telix and our continued commitment to ...

Cardinal Health has announced plans for a multi-million-dollar expansion that will include the addition of nearly 100 jobs. ... president of nuclear and precision health solutions at Cardinal, ...

SYDNEY, Dec. 2, 2021 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the growing needs ...

Cardinal Health Inc is exploring a potential sale of its nuclear medicine unit as part of a larger review of its business, Bloomberg News reported on Tuesday, citing people familiar with the matter.

Mike Pintek, President of Cardinal Health Nuclear & Precision Health Solutions, added, “This new agreement builds upon our successful relationship with Telix and our continued commitment to ...

Mike Pintek, President of Cardinal Health Nuclear & Precision Health Solutions, added, “We are pleased to continue to build on our relationship with Telix, which now includes the distribution of ...